Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Trifunovic, Danijela ^a,b   Stankovic, Sanja ^b   Sobic Saranovic, Dragana ^a,b   Marinkovic, Jelena ^b   Petrovic, Marija ^a   Orlic, Dejan ^a,b   Beleslin, Branko ^a,b   Banovic, Marko ^a,b   Vujisic Tesic, Bosiljka ^a,b   Petrovic, Milan ^a,b   Nedeljkovic, Ivana ^a,b   Stepanovic, Jelena ^a,b   Djordjevic Dikic, Ana ^a,b   Tesic, Milorad ^a   Djukanovic, Nina ^a   Petrovic, Olga ^a   Vasovic, Olga ^c   Nestorovic, Emilija ^a   Kostic, Jelena ^a   Ristic, Arsen ^a,b   Ostojic, Miodrag ^b,c   more..

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c The Institute for Gerontology   (Serbia)

Author keywords

Acute myocardial infarction; Coronary microcirculation; Infarct size; Insulin resistance; ST E resolution

Indexed keywords

GLYCERYL TRINITRATE; HEMOGLOBIN A1C; INSULIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BODY MASS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; GLUCOSE BLOOD LEVEL; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMPAIRED CORONARY MICROCIRCULATORY FUNCTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROCIRCULATION; MYOCARDIAL PERFUSION IMAGING; PERCUTANEOUS CORONARY INTERVENTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; AGED; CORONARY CIRCULATION; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES;

EID: 84899485421     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-73     Document Type: Article

References (63)

1. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33(20):2569-2619. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC).
2. Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?. Eur Heart J 2007, 28(7):788-97. 10.1093/eurheartj/ehl501, 17347176.
3. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54(4):281-292. 10.1016/j.jacc.2009.03.054, 19608025.
4. Robins SJ, Lyass A, Zachariah JP, Massaro JM, Vasan RS. Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2011, 31:1208-1214. 10.1161/ATVBAHA.110.219055, 3087170, 21311041.
5. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 2007, 30:318-324. 10.2337/dc06-0919, 17259501.
6. Arnold SV, Lipska KJ, Li Y, Goyal A, Maddox TM, McGuire DK, Spertus JA, Kosiborod M. The reliability and prognosis of in-hospital diagnosis of metabolic syndrome in the setting of acute myocardial infarction. J Am Coll Cardiol 2013, 62(8):704-708. 10.1016/j.jacc.2013.02.062, 23563136.
7. Uchida Y, Ichimiya S, Ishii H, Kanashiro M, Watanabe J, Yoshikawa D, Takeshita K, Sakai S, Amano T, Matsubara T, Murohara T. Impact of metabolic syndrome on various aspects of microcirculation and major adverse cardiac events in patients with ST-segment elevation myocardial infarction. Circ J 2012, 76(8):1972-1979. 10.1253/circj.CJ-11-1299, 22664935.
8. Tartan Z, Ozer N, Uyarel H, Akgul O, Gul M, Cetin M, Kasikcioglu H, Cam N. Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction. Nutr Metab Cardiovasc Dis 2008, 18(6):441-447. 10.1016/j.numecd.2007.02.015, 17981019.
9. Wensley I, Salaveria K, Bulmer AC, Donner DG, du Toit EF. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. Exp Physiol 2013, 98(11):1552-1564. 10.1113/expphysiol.2013.074948, 23851919.
10. Bøhmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S. The association between metabolic syndrome and infarct size in patients with acute myocardial infarction. Scand J Clin Lab Invest 2010, 70(4):287-293. 10.3109/00365513.2010.481819, 20429699.
11. Kranjcec D, Altabas V. Metabolic syndrome influencing infarct size and heart failure in patients with acute coronary syndrome: does gender matter?. Endocr J 2012, 59(12):1065-1076. 10.1507/endocrj.EJ12-0131, 22971940.
12. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 2006, 7(1):7-11. 10.1016/j.carrev.2005.10.007, 16513517.
13. Reddy KJ, Singh M, Bangit JR, Batsell RR. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review. J Cardiovasc Med (Hagerstown) 2010, 11:633-647. 10.2459/JCM.0b013e328333645a, 20164784.
14. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007, 49(21):2112-2119. 10.1016/j.jacc.2007.01.088, 17531661.
15. Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE, Maddox TM, McGuire DK, Spertus JA, Horwitz PA. Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol 2013, 33(9):2245-2251. 10.1161/ATVBAHA.113.301585, 23868937.
16. Cadeddu C, Nocco S, Piano D, Deidda M, Cossu E, Baroni MG, Mercuro G. Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects. Cardiovasc Diabetol 2013, 12(1):66. 10.1186/1475-2840-12-66, 3637195, 23590337.
17. Uetani T, Amano T, Harada K, Kitagawa K, Kunimura A, Shimbo Y, Harada K, Yoshida T, Kato B, Kato M, Marui N, Nanki M, Hotta N, Ishii H, Matsubara T, Murohara T. Impact of insulin resistance on post-procedural myocardial injury and clinical outcomes in patients who underwent elective coronary interventions with drug-eluting stents. JACC Cardiovasc Interv 2012, 5(11):1159-1167. 10.1016/j.jcin.2012.07.008, 23174640.
18. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF. Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction. Diab Vasc Dis Res 2011, 8(1):35-42. 10.1177/1479164110396744, 21262869.
19. Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 2009, 26(10):856-862. 10.1097/EJA.0b013e32832a235c, 19367169.
20. Lazzeri C, Valente S, Chiostri M, Attanà P, Mattesini A, Gensini GF. Acute insulin resistance assessed by the homeostatic model assessment in acute coronary syndromes without previously known diabetes. Angiology 2013, [Epub ahead of print]. doi:10.1177/0003319713489018.
21. Sanjuan R, Blasco ML, Huerta R, Palacios L, Carratala A, Nunyez J, Sanchis J. Insulin resistance and short-term mortality in patients with acute myocardial infarction. Int J Cardiol 2014, 172(2):e269-e270. 10.1016/j.ijcard.2013.12.207, 24485226.
22. Nishio K, Shigemitsu M, Kusuyama T, Fukui T, Kawamura K, Itoh S, Konno N, Katagiri T. Insulin resistance in nondiabetic patients with acute myocardial infarction. Cardiovasc Revasc Med 2006, 7(2):54-60. 10.1016/j.carrev.2005.12.004, 16757401.
23. Lazzeri C, Valente S, Chiostri M, Attanà P, Picariello C, Gensini GF. The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia. Acta Diabetol 2013, 50(3):293-300. 10.1007/s00592-011-0325-6, 21984048.
24. Zarich WS, Nesto RW. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 2007, 115(18):e436-e439. 10.1161/CIRCULATIONAHA.105.535732, 17485582.
25. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA). Diabetes Care 2005, 28(10):2551-2553. 10.2337/diacare.28.10.2551, 16186299.
26. Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H Japanese Acute Coronary Syndrome Study Investigators Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005, 150(4):814-820. 10.1016/j.ahj.2004.12.020, 16209987, Japanese Acute Coronary Syndrome Study Investigators.
27. Cruz-Gonzalez I, Chia S, Raffel OC, Sanchez-Ledesma M, Senatore F, Wackers FJ, Nathan DM, Jang IK. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-elevation myocardial infarction. Diabetes Res Clin Pract 2010, 88(1):97-102. 10.1016/j.diabres.2010.01.001, 20083319.
28. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Umemura T, Nakamura S, Yoshida M. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 2003, 146(4):674-678. 10.1016/S0002-8703(03)00167-4, 14564322.
29. García RG, Rincón MY, Arenas WD, Silva SY, Reyes LM, Ruiz SL, Ramirez F, Camacho PA, Luengas C, Saaibi JF, Balestrini S, Morillo C, López-Jaramillo P. Hyperinsulinemia is a predictor of new cardiovascular events in Colombina patients with a first myocardial infarction. Int J Cardiol 2011, 148(1):85-90. 10.1016/j.ijcard.2009.10.030, 19923024.
30. Kragelund C, Snorgaard O, Køber L, Bengtsson B, Ottesen M, Højberg S, Olesen C, Kjaergaard JJ, Carlsen J, Torp-Petersen C TRACE Study Group Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients. Eur Heart J 2004, 25(21):1891-1897. 10.1016/j.ehj.2004.07.033, 15522467, TRACE Study Group.
31. Panza-Nduli J, Coulic V, Willems D, Devriendt J, Gottignies P, Staroukine M, De Bels D. Influence of blood insulin measurement in acute coronary syndrome. Crit Pathw Cardiol 2011, 10(4):185-188. 10.1097/HPC.0b013e318238c5ca, 22089275.
32. Moura FA, Carvalho LS, Cintra RM, Martins NV, Figueiredo VN, Quinaglia E, Silva JC, Almeida OL, Coelho OR, Sposito AC. Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic hyperinsulinemic clamp. Am J Physiol Endocrinol Metab 2014, 306(4):E399-E403. 10.1152/ajpendo.00566.2013, 24347056.
33. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl.1):S81-S90. American Diabetes Association.
34. Balkau B, Charles M for European Group for the Study of Insulin Resistance (EGIR) Comment on the provisional report from the WHO consultation. Diabet Med 1999, 16:442-443. for European Group for the Study of Insulin Resistance (EGIR).
35. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F Chronic Kidney Disease Epidemiology Collaboration Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254. 10.7326/0003-4819-145-4-200608150-00004, 16908915, Chronic Kidney Disease Epidemiology Collaboration.
36. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985, 5(3):587-592. 10.1016/S0735-1097(85)80380-6, 3156171.
37. Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987, 75(4):817-829. 10.1161/01.CIR.75.4.817, 3103950.
38. Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 2008, 118:1335-1346. 10.1161/CIRCULATIONAHA.108.767772, 18779444.
39. Saraste M, Koskenvuo J, Knuuti J, Toikka J, Laine H, Niemi P, Sakuma H, Hartiala J. Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001, 21(1):114-122. 10.1046/j.1365-2281.2001.00296.x, 11168305.
40. Djordjevic-Dikic A, Beleslin B, Stepanovic J, Giga V, Tesic M, Dobric M, Stojkovic S, Nedeljkovic M, Vukcevic V, Dikic N, Petrasinovic Z, Nedeljkovic I, Tomasevic M, Vujisic-Tesic B, Ostojic M. Prediction of myocardial functional recovery by noninvasive evaluation of basal and hyperemic coronary flow in patients with previous myocardial infarction. J Am Soc Echocardiogr 2011, 24(5):573-581. 10.1016/j.echo.2011.01.004, 21514503.
41. Rigo F, Varga Z, Di Pede F, Grassi G, Turiano G, Zuin G, Coli U, Raviele A, Picano E. Early assessment of coronary flow reserve by transthoracic Doppler echocardiography predicts late remodeling in reperfused anterior myocardial infarction. J Am Soc Echocardiogr 2004, 17(7):750-755. 10.1016/j.echo.2004.04.023, 15220900.
42. Li L, Messina JL. Acute insulin resistance following injury. Trends Endocrinol Metab 2009, 20(9):429-435. 10.1016/j.tem.2009.06.004, 2939005, 19800814.
43. Pretty CG, Le Compte AJ, Chase JG, Shaw GM, Preiser JC, Penning S, Desaive T. Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control. Ann Intensive Care 2012, 2(1):17. 10.1186/2110-5820-2-17, 3464183, 22703645.
44. Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O. Insulin resistance and inflammation markers in myocardial infarction. J Inflamm Res 2013, 6:83-90. 3699291, 23837002.
45. Xiao C, Giacca A, Carpentier A, Lewis GF. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia 2006, 49:1371-1379. 10.1007/s00125-006-0211-x, 16596361.
46. Wolpert HA, Atakov-Castillo A, Smith SA, Steil GM. Implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care 2013, 36(4):810-816. 10.2337/dc12-0092, 3609492, 23193216.
47. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369:201-207. 10.1016/S0140-6736(07)60108-1, 17240286.
48. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010, 375(9716):735-742. 10.1016/S0140-6736(09)61965-6, 20167359.
49. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 2011, 305(24):2556-2564. 10.1001/jama.2011.860, 21693744.
50. Yong AS, Fearon WF. Coronary microvascular dysfunction after ST-segment-elevation myocardial infarction: local or global phenomenon?. Circ Cardiovasc Interv 2013, 6(3):201-203. 10.1161/CIRCINTERVENTIONS.113.000462, 23780293.
51. Eroglu S, Sade LE, Bozbas H, Haberal A, Ozbicer S, Demir O, Muderrisoglu H. Association of serum adiponectin levels and coronary flow reserve in women with normal coronary angiography. Eur J Cardiovasc Prev Rehabil 2009, 16(3):290-296. 10.1097/HJR.0b013e32831f1b8a, 19404197.
52. Kondo I, Mizushige K, Hirao K, Nozaki S, Tsuji T, Masugata H, Kohno M, Matsuo H. Ultrasonographic assessment of coronary flow reserve and abdominal fat in obesity. Ultrasound Med Biol 2001, 27(9):1199-1205. 10.1016/S0301-5629(01)00427-6, 11597360.
53. Snoer M, Monk-Hansen T, Olsen RH, Pedersen LR, Simonsen L, Rasmusen H, Dela F, Prescott E. Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function. Cardiovasc Diabetol 2012, 11:97. 10.1186/1475-2840-11-97, 3444364, 22889317.
54. Timmer J, Ottervanger J, de Boer M, Dambrink JE, Hoorntje JCA, Gosselink ATM, Suryapranata H, Zijlstra F, Van't Hof AWJ for the Zwolle Myocardial Infarction Study Group Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005, 45(7):999-1002. 10.1016/j.jacc.2004.12.050, 15808754, for the Zwolle Myocardial Infarction Study Group.
55. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003, 41(1):1-7. 10.1016/S0735-1097(02)02626-8, 12570936.
56. Monnier L, Mas E, Ginet C, Michel F, Willon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687. 10.1001/jama.295.14.1681, 16609090.
57. Chang J, Zhang G, Zhang L, Hou YP, Liu XL, Zhang L. High admission glucose levels increase Fas apoptosis and mortality in patients with acute ST-elevation myocardial infarction: a prospective cohort study. Cardiovasc Diabetol 2013, 12(1):171. 10.1186/1475-2840-12-171, 3842819, 24229414.
58. Sundell J, Nuutila P, Laine H, Luotolahti M, Kalliokoski K, Raitakari O, Knuuti J. Dose-dependent vasodilating effects of insulin on adenosine-stimulated myocardial blood flow. Diabetes 2002, 51(4):1125-1130. 10.2337/diabetes.51.4.1125, 11916935.
59. Laine H, Nuutila P, Luotolahti M, Meyer C, Elomaa T, Koskinen P, Ronnemaa T, Knuuti J. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. J Clin Endocrinol Metab 2000, 85(5):1868-1873.
60. Rocchini AP, Wilson RF, Marker P, Cervenka T. Metabolic and hemodynamic effects of a graded intracoronary insulin infusion in normal and fat anesthetized dogs: a preliminary study. Hypertension 1996, 27(3):354-359. 10.1161/01.HYP.27.3.354, 8698437.
61. Sundell J, Laine H, Luotolahti M, Kalliokoski K, Raitakari O, Nuutila P, Knuuti J. Obesity affects myocardial vasoreactivity and coronary flow response to insulin. Obes Res 2002, 10(7):617-624. 10.1038/oby.2002.84, 12105283.
62. L'Huillier I, Zeller M, Mock L, Beer JC, Laurent Y, Sicard P, Vincent-Martin M, Lorgis L, Makki H, Wolf JE, Freysz M, Cottin Y. Relation of hyperglycemia to ST-segment resolution after reperfusion for acute myocardial infarction (from Observatoire des Infarctus de Côte-d'Or Survey [RICO]). Am J Cardiol 2006, 98(2):167-171. 10.1016/j.amjcard.2006.01.087, 16828586.
63. Chi HJ, Zhang DP, Xu Y, Yang ZS, Wang LF, Cui L, Yang XC. Relation of hyperglycemia to ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction. Chin Med J (Engl) 2007, 120(21):1874-1877.